Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

Press releases published on September 1, 2026

Sep. 1, 2026

All Episodes of Al-Khwarizmi: Father of Algebra & the Algorithm Are Now Available for Free on YouTube

Indeterminate EIN Presswire

Sep. 1, 2026

AuditFile Launches Agentic AI Orchestrator Suite

Indeterminate EIN Presswire

Sep. 1, 2026

Labarna AI Publishes Definitive Enterprise CIO Playbook for UAE National AI Strategy 2031 Compliance

Indeterminate EIN Presswire

Sep. 1, 2026

Complete 6-Month DEScover Results for Solaris DE to be Presented at CIRSE 2026

Indeterminate EIN Presswire

Sep. 1, 2026

Enovix’s TAA-Compliant Battery Manufacturing Strengthens Position with U.S. Defense Supply Chain

Indeterminate GlobeNewswire

Sep. 1, 2026

ZenaTech presentará el crecimiento de Drones como Servicio y las soluciones de defensa de ZenaDrone en una serie de eventos para inversionistas y de defensa en EE. UU. y en todo el mundo

Indeterminate GlobeNewswire

Sep. 1, 2026

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

Indeterminate GlobeNewswire

Sep. 1, 2026

Cerebras ja Compute Nordic Finland rakentavat uuden 165 megawatin datakeskuksen Mikkeliin

Indeterminate GlobeNewswire

Sep. 1, 2026

IBM Joins MEBIS 2026 as Title Sponsor in Dubai, Advancing AI-powered Banking Innovation

Indeterminate EIN Presswire

Sep. 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 1, 2026

Ero to Host 2026 Capital Markets Day

Indeterminate GlobeNewswire

Sep. 1, 2026

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 1, 2026

aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

Indeterminate GlobeNewswire

Sep. 1, 2026

Teva to Present at Morgan Stanley, J.P. Morgan and BofA Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 1, 2026

Cellectis annonce sa participation à plusieurs conférences investisseurs

Indeterminate GlobeNewswire

Sep. 1, 2026

Cellectis Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Tarsus to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire